Doximity (DOCS) – Research Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for Doximity (NYSE: DOCS):

• 1/10/2026 – Doximity was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 1/9/2026 – Doximity was upgraded by analysts at The Goldman Sachs Group, Inc. from a “strong sell” rating to a “hold” rating.
• 1/8/2026 – Doximity was upgraded by analysts at Truist Financial Corporation from a “hold” rating to a “strong-buy” rating.
• 1/8/2026 – Doximity was upgraded by analysts at Royal Bank Of Canada to a “moderate buy” rating.
• 12/24/2025 – Doximity had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/18/2025 – Doximity had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/14/2025 – Doximity was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/12/2025 – Doximity is now covered by analysts at Weiss Ratings. They set a “hold (c+)” rating on the stock.
• 12/8/2025 – Doximity was upgraded by analysts at Barclays PLC to a “strong-buy” rating.

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.